Coronamycins, peptide antibiotics produced by a verticillate Streptomyces sp (MSU-2110) endophytic on Monstera sp.

被引:108
|
作者
Ezra, D
Castillo, UF
Strobel, GA [1 ]
Hess, WM
Porter, H
Jensen, JB
Condron, MAM
Teplow, DB
Sears, J
Maranta, M
Hunter, M
Weber, B
Yaver, D
机构
[1] Montana State Univ, Dept Plant Sci, Bozeman, MT 59717 USA
[2] Montana State Univ, Dept Chem, Bozeman, MT 59717 USA
[3] Brigham Young Univ, Dept Integrat Biol, Provo, UT 84602 USA
[4] Brigham Young Univ, Dept Microbiol, Provo, UT 84602 USA
[5] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
[6] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA
来源
MICROBIOLOGY-SGM | 2004年 / 150卷
关键词
D O I
10.1099/mic.0.26645-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Coronamycin is a complex of novel peptide antibiotics with activity against pythiaceous fungi and the human fungal pathogen Cryptococcus neoformans. It is also active against the malarial parasite, Plasmodium falciparum, with an IC50 of 9(.)0 ng ml(-1). Coronamycin is produced by a verticillate Streptomyces sp. isolated as an endophyte from an epiphytic vine, Monstera sp., found in the Manu region of the upper Amazon of Peru. Bioassay-guided fractionation of the fermentation broths of this endophyte on silica gel and H PLC chromatography yielded two principal, inseparable, peptides with masses of 1217(.)9 and 1203(.)8 Da. Three other minor, but related components, are also present in the preparation. Amino acid analysis of coronamycin revealed residues of component 1, component 2, methionine, tyrosine and leucine at a ratio of 2 : 2 :1 :1 : 3. Other compounds with antifungal activities are also produced by this endophytic streptomycete.
引用
收藏
页码:785 / 793
页数:9
相关论文
共 50 条
  • [11] Bioremediation of Copper with Endophytic Bacteria Bacillus sp. and Streptomyces griseus
    Ozkoc, Hulya Boke
    Aliustaoglu, Mirac Tansu
    Senturk, Ilknur
    JOURNAL OF ENVIRONMENTAL ENGINEERING, 2023, 149 (11)
  • [12] Metabolites of Streptomyces sp., an endophytic actinomycete from Alpinia oxyphylla
    Zhou, Hao
    Yang, Yabin
    Peng, Tianfeng
    Li, Wei
    Zhao, Lixing
    Xu, Lihua
    Ding, Zhongtao
    NATURAL PRODUCT RESEARCH, 2014, 28 (04) : 265 - 267
  • [13] Bisanthraquinone metabolites produced by the endophytic fungus Diaporthe sp.
    Agusta, A
    Ohashi, K
    Shibuya, H
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2006, 54 (04) : 579 - 582
  • [14] TAKAOKAMYCIN, A NEW PEPTIDE ANTIBIOTIC PRODUCED BY STREPTOMYCES SP
    OMURA, S
    MAMADA, H
    WANG, NJ
    IMAMURA, N
    OIWA, R
    IWAI, Y
    MUTO, N
    JOURNAL OF ANTIBIOTICS, 1984, 37 (07): : 700 - 705
  • [15] Two novel nucleosidyl–peptide antibiotics: Sansanmycin F and G produced by Streptomyces sp SS
    Yunying Xie
    Hongzhang Xu
    Chenghang Sun
    Ying Yu
    Ruxian Chen
    The Journal of Antibiotics, 2010, 63 : 143 - 146
  • [16] STUDIES ON ANTIBIOTICS PRODUCED BY PSYCHROPHILIC MICROORGANISMS .1. PRODUCTION OF ANTIBIOTICS BY A PSYCHROPHILE, STREPTOMYCES SP. NO. 81
    OGATA, K
    YOSHIDA, N
    OHSUGI, M
    TANI, Y
    AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1971, 35 (01): : 79 - &
  • [17] Study of dextranase properties produced by Streptomyces sp. AM
    Alili, Malika
    Abdelwahab, Amani
    Munim, Ghazi
    JOURNAL OF BIOTECHNOLOGY, 2018, 280 : S50 - S51
  • [18] Ushikulides A and B, Immunosuppressants Produced by a Strain of Streptomyces sp.
    Kosaku Takahashi
    Teruhiko Yoshihara
    Kazuhiko Kurosawa
    The Journal of Antibiotics, 2005, 58 : 420 - 424
  • [19] Chrolactomycin, a novel antitumor antibiotic produced by Streptomyces sp.
    Nakai, R
    Kakita, S
    Asai, A
    Chiba, S
    Akinaga, S
    Mizukami, T
    Yamashita, Y
    JOURNAL OF ANTIBIOTICS, 2001, 54 (10): : 836 - 839
  • [20] Two New Butenolides Produced by an Actinomycete Streptomyces sp.
    Wang, Tang
    Jiang, Yi
    Ma, Kai-Xia
    Li, Yi-Qing
    Huang, Rong
    Xie, Xiao-Song
    Wu, Shao-Hua
    CHEMISTRY & BIODIVERSITY, 2014, 11 (06) : 929 - 933